AorticLab™ is pleased to announce the successful achievement of CE certification for FLOWer™, an innovative transcatether embolic protection device (EPD) indicated for the cerebral and systemic protection of patients undergoing transcatheter aortic valve replacement (TAVI) procedures. The CE certification of FLOWer, a Class III medical
AorticLab has obtained ISO13485 certification for the design and development of its products. It certifies that Aorticlab has established and is maintaining a quality management system, which meets the requirements of the standard. We are proud: it means we’ve made a good job, as a
AorticLab, a leading innovator of cutting-edge technology solutions to treat aortic stenosis and improve patients’ safety, based in Colleretto Giacosa Bioindustry Park – Turin Italy, – today announced the positive completion of the first three human procedures of its FLOWer embolic protection filter. The first
Presentation for innovation GEMINI Transcatheter debridement device Dr F. De Marco EMBRACE Transcatheter antiembolic filter Dr F. Scalise www.pcronline.com
Embrace Transcatheter Antiembolic Filter Presentation for “Best innovation Competition” Dr. Filippo Scalise Innovation Award
Degenerative aortic stenosis (AS) is the most common heart valve disease in developed countries. The prevalence of AS increases with age and varies from 0.2% at ages 50 to 59 years to 1.3% at 60 to 69 years, 3.9% at 70 to 79 years, and
